VC-backed Trevena names new board member
Trevena has appointed Dr. Francois Nader to its board of directors. Dr. Nader is the president and CEO of NPS Pharmaceuticals.Based in King of Prussia, Penn., Trevena is a clinical stage biopharmaceutical company that develops therapeutics that target G protein coupled receptors. It is backed by Alta Partners, New Enterprise Associates, Polaris Partners, Forest Labs and HealthCare Ventures.
8 January 2014•3 mins read
